138 related articles for article (PubMed ID: 36099888)
21. Neutrophil/Lymphocyte Ratio, Lymphocyte/Monocyte Ratio, and Absolute Lymphocyte Count/Absolute Monocyte Count Prognostic Score in Diffuse Large B-Cell Lymphoma: Useful Prognostic Tools in the Rituximab Era.
Ho CL; Lu CS; Chen JH; Chen YG; Huang TC; Wu YY
Medicine (Baltimore); 2015 Jun; 94(24):e993. PubMed ID: 26091479
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Different Phenotypes of Locally Advanced Breast Cancer During Neoadjuvant Systemic Treatment.
Muñoz-Montaño W; Cabrera-Galeana P; Alvarado-Miranda A; Villarreal-Garza C; Mohar A; Olvera A; Bargallo-Rocha E; Lara-Medina F; Arrieta O
Clin Breast Cancer; 2020 Aug; 20(4):307-316.e1. PubMed ID: 32305297
[TBL] [Abstract][Full Text] [Related]
23. Prediction of survival after eribulin chemotherapy for breast cancer by absolute lymphocyte counts and progression types.
Morisaki T; Kashiwagi S; Asano Y; Goto W; Takada K; Ishihara S; Shibutani M; Tanaka H; Hirakawa K; Ohira M
World J Surg Oncol; 2021 Nov; 19(1):324. PubMed ID: 34775950
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of the ratio of absolute neutrophil to lymphocyte counts for breast cancer patients with ER/PR-positivity and HER2-negativity in neoadjuvant setting.
Koh YW; Lee HJ; Ahn JH; Lee JW; Gong G
Tumour Biol; 2014 Oct; 35(10):9823-30. PubMed ID: 24986572
[TBL] [Abstract][Full Text] [Related]
25. Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy.
Romano A; Parrinello NL; Vetro C; Chiarenza A; Cerchione C; Ippolito M; Palumbo GA; Di Raimondo F
Ann Hematol; 2018 Jun; 97(6):1009-1018. PubMed ID: 29442162
[TBL] [Abstract][Full Text] [Related]
26. Baseline Lymphopenia: A Predictor Of Poor Outcomes In HER2 positive Metastatic Breast Cancer Treated With Trastuzumab.
Che YQ; Zhang Y; Wang D; Liu HY; Shen D; Luo Y
Drug Des Devel Ther; 2019; 13():3727-3734. PubMed ID: 31754298
[TBL] [Abstract][Full Text] [Related]
27. The prognostic importance of glucose-to-lymphocyte ratio and uric acid in metastatic breast cancer patients treated with Cdk 4/6 inhibitors.
Yilmaz H; Nigdelioglu B; Aytac A; Turan M; Oktay E; Yersal O; Barutca S
Future Oncol; 2022 Sep; 18(27):3043-3053. PubMed ID: 36062468
[TBL] [Abstract][Full Text] [Related]
28. Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer.
Patel DA; Xi J; Luo J; Hassan B; Thomas S; Ma CX; Campian JL
Breast Cancer Res Treat; 2019 Apr; 174(2):443-452. PubMed ID: 30604000
[TBL] [Abstract][Full Text] [Related]
29. Pre-treatment absolute lymphocyte count predicts for improved survival in human papillomavirus (HPV)-driven oropharyngeal squamous cell carcinoma.
Kreinbrink PJ; Li J; Parajuli S; Wise-Draper TM; Choi DL; Tang AL; Takiar V
Oral Oncol; 2021 May; 116():105245. PubMed ID: 33901866
[TBL] [Abstract][Full Text] [Related]
30. Improved prognosis of low baseline neutrophil-to-lymphocyte ratio is significantly exclusive in breast cancer patients with high absolute counts of lymphocytes.
Fujimoto Y; Ozawa H; Higuchi T; Miyagawa Y; Bun A; Imamura M; Miyoshi Y
Mol Clin Oncol; 2019 Feb; 10(2):275-284. PubMed ID: 30680208
[TBL] [Abstract][Full Text] [Related]
31. Pretreatment Neutrophil-to-Lymphocyte Ratio and Lymphocyte Recovery: Independent Prognostic Factors for Survival in Pediatric Sarcomas.
Vasquez L; León E; Beltran B; Maza I; Oscanoa M; Geronimo J
J Pediatr Hematol Oncol; 2017 Oct; 39(7):538-546. PubMed ID: 28697168
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Nutritional Index Is Superior to Neutrophil-to-lymphocyte Ratio as a Prognostic Marker in Metastatic Breast Cancer Patients Treated With Eribulin.
Oba T; Maeno K; Ono M; Ito T; Kanai T; Ito KI
Anticancer Res; 2021 Jan; 41(1):445-452. PubMed ID: 33419842
[TBL] [Abstract][Full Text] [Related]
33. Indices of peripheral leukocytes predict longer overall survival in breast cancer patients on eribulin in Japan.
Takahashi M; Inoue K; Mukai H; Yamanaka T; Egawa C; Miyoshi Y; Sakata Y; Muramoto K; Ikezawa H; Matsuoka T; Tsurutani J
Breast Cancer; 2021 Jul; 28(4):945-955. PubMed ID: 33677779
[TBL] [Abstract][Full Text] [Related]
34. The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma.
Huszno J; Kolosza Z; Mrochem-Kwarciak J; Rutkowski T; Skladowski K
Oncology; 2019; 97(1):7-17. PubMed ID: 31048577
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of the neutrophil-to-lymphocyte ratio in oligometastatic breast cancer.
Inoue Y; Fujishima M; Ono M; Masuda J; Ozaki Y; Maeda T; Uehiro N; Takahashi Y; Kobayashi T; Sakai T; Osako T; Ueno T; Ohno S
Breast Cancer Res Treat; 2022 Nov; 196(2):341-348. PubMed ID: 36153381
[TBL] [Abstract][Full Text] [Related]
36. The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages.
Koh YW; Kang HJ; Park C; Yoon DH; Kim S; Suh C; Go H; Kim JE; Kim CW; Huh J
Oncologist; 2012; 17(6):871-80. PubMed ID: 22588324
[TBL] [Abstract][Full Text] [Related]
37. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?
Ulas A; Avci N; Kos T; Cubukcu E; Olmez OF; Bulut N; Degirmenci M
J BUON; 2015; 20(3):714-22. PubMed ID: 26214622
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of the ratio of absolute neutrophil count to absolute lymphocyte count in classic Hodgkin lymphoma.
Koh YW; Kang HJ; Park C; Yoon DH; Kim S; Suh C; Kim JE; Kim CW; Huh J
Am J Clin Pathol; 2012 Dec; 138(6):846-54. PubMed ID: 23161719
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: An updated meta-analysis of 17079 individuals.
Guo W; Lu X; Liu Q; Zhang T; Li P; Qiao W; Deng M
Cancer Med; 2019 Aug; 8(9):4135-4148. PubMed ID: 31197958
[TBL] [Abstract][Full Text] [Related]
40. Significant Association Between Low Baseline Neutrophil-to-Lymphocyte Ratio and Improved Progression-free Survival of Patients With Locally Advanced or Metastatic Breast Cancer Treated With Eribulin But Not With Nab-Paclitaxel.
Miyagawa Y; Araki K; Bun A; Ozawa H; Fujimoto Y; Higuchi T; Nishimukai A; Kira A; Imamura M; Takatsuka Y; Miyoshi Y
Clin Breast Cancer; 2018 Oct; 18(5):400-409. PubMed ID: 29605174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
